Evidence map›Paper›PMID 31185988›Full record

ArticleCardiovascular diabetology2019

Machine-learning to stratify diabetic patients using novel cardiac biomarkers and integrative genomics.

Quincy A Hathaway, Skyler M Roth, Mark V Pinti, Daniel C Sprando, Amina Kunovac, Andrya J Durr, Chris C Cook, Garrett K Fink, Tristen B Cheuvront, Jasmine H Grossman and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cardiovascular diabetology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Epigenetics in diabetic cardiomyopathy.Clinical epigenetics · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Quincy A HathawayDivision of Exercise Physiology, West Virginia University School of Medicine, PO Box 9227, 1 Medical Center Drive, Morgantown, WV, 26505, USA.
Skyler M RothDepartment of Chemical and Biomedical Engineering, West Virginia University, Morgantown, WV, 26505, USA.
Mark V PintiWest Virginia University School of Pharmacy, Morgantown, WV, 26505, USA.
Daniel C SprandoWest Virginia University School of Medicine, Morgantown, WV, 26505, USA.
Amina KunovacDivision of Exercise Physiology, West Virginia University School of Medicine, PO Box 9227, 1 Medical Center Drive, Morgantown, WV, 26505, USA.
Andrya J DurrDivision of Exercise Physiology, West Virginia University School of Medicine, PO Box 9227, 1 Medical Center Drive, Morgantown, WV, 26505, USA.
Chris C CookCardiovascular and Thoracic Surgery, West Virginia University School of Medicine, Morgantown, WV, 26505, USA.
Garrett K FinkDivision of Exercise Physiology, West Virginia University School of Medicine, PO Box 9227, 1 Medical Center Drive, Morgantown, WV, 26505, USA.
Tristen B CheuvrontDepartment of Chemical and Biomedical Engineering, West Virginia University, Morgantown, WV, 26505, USA.
Jasmine H GrossmanDepartment of Chemical and Biomedical Engineering, West Virginia University, Morgantown, WV, 26505, USA.
Ghadah A AljahliDepartment of Chemical and Biomedical Engineering, West Virginia University, Morgantown, WV, 26505, USA.
Andrew D TaylorDivision of Exercise Physiology, West Virginia University School of Medicine, PO Box 9227, 1 Medical Center Drive, Morgantown, WV, 26505, USA.
Andrew P GirominiWest Virginia University School of Medicine, Morgantown, WV, 26505, USA.
Jessica L AllenDepartment of Chemical and Biomedical Engineering, West Virginia University, Morgantown, WV, 26505, USA.
John M HollanderDivision of Exercise Physiology, West Virginia University School of Medicine, PO Box 9227, 1 Medical Center Drive, Morgantown, WV, 26505, USA. jhollander@hsc.wvu.edu.ORCID 0000-0001-5724-694X
West Virginia University · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Sally Lynn Hodder · 2012 to 2026
$81.0M
WV INBRE: The Inhibitor of Growth Family Member 4 (ING4) inhibits L-Type Amino Acid Transporter 1 (LAT1) expression to suppress Breast CancerP20GM103434 · NIGMS · MARSHALL UNIVERSITY · PI GARY O RANKIN · 2012 to 2026
$61.1M
miRNA Regulation of the Mitochondrial GenomeR01HL128485 · NHLBI · WEST VIRGINIA UNIVERSITY · PI HOLLANDER, JOHN M · 2017 to 2019
$1.3M
NHLBI NIH HHS R01 HL128485NIGMS NIH HHS P20 GM103434NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

backgroundDiabetes mellitus is a chronic disease that impacts an increasing percentage of people each year. Among its comorbidities, diabetics are two to four times more likely to develop cardiovascular diseases. While HbA1c remains the primary diagnostic for diabetics, its ability to predict long-term, health outcomes across diverse demographics, ethnic groups, and at a personalized level are limited. The purpose of this study was to provide a model for precision medicine through the implementation of machine-learning algorithms using multiple cardiac biomarkers as a means for predicting diabetes mellitus development.

methodsRight atrial appendages from 50 patients, 30 non-diabetic and 20 type 2 diabetic, were procured from the WVU Ruby Memorial Hospital. Machine-learning was applied to physiological, biochemical, and sequencing data for each patient. Supervised learning implementing SHapley Additive exPlanations (SHAP) allowed binary (no diabetes or type 2 diabetes) and multiple classification (no diabetes, prediabetes, and type 2 diabetes) of the patient cohort with and without the inclusion of HbA1c levels. Findings were validated through Logistic Regression (LR), Linear Discriminant Analysis (LDA), Gaussian Naïve Bayes (NB), Support Vector Machine (SVM), and Classification and Regression Tree (CART) models with tenfold cross validation.

resultsTotal nuclear methylation and hydroxymethylation were highly correlated to diabetic status, with nuclear methylation and mitochondrial electron transport chain (ETC) activities achieving superior testing accuracies in the predictive model (~ 84% testing, binary). Mitochondrial DNA SNPs found in the D-Loop region (SNP-73G, -16126C, and -16362C) were highly associated with diabetes mellitus. The CpG island of transcription factor A, mitochondrial (TFAM) revealed CpG24 (chr10:58385262, P = 0.003) and CpG29 (chr10:58385324, P = 0.001) as markers correlating with diabetic progression. When combining the most predictive factors from each set, total nuclear methylation and CpG24 methylation were the best diagnostic measures in both binary and multiple classification sets.

conclusionsUsing machine-learning, we were able to identify novel as well as the most relevant biomarkers associated with type 2 diabetes mellitus by integrating physiological, biochemical, and sequencing datasets. Ultimately, this approach may be used as a guideline for future investigations into disease pathogenesis and novel biomarker discovery.

Indexed as

Epigenesis, GeneticModels, GeneticSupport Vector MachineSystems IntegrationCpG IslandsDiabetes Mellitus, Type 2Diabetic CardiomyopathiesDisease ProgressionDNA MethylationDNA, MitochondrialFemaleGenetic MarkersGenetic Predisposition to DiseaseGenomicsGlycated HemoglobinHumansDNA, MitochondrialGenetic MarkersGlycated Hemoglobinhemoglobin A1c protein, humanCARTEpigeneticsHeartMachine-learningMitochondriaSHAP

Identifiers

PMID31185988
PMCPMC6560734
OpenAlexW2949187711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.